Belgium Sets €6.73 Billion Budget for Specialty Pharmaceutical Benefits

The Belgian government has allocated €6.73 billion for specialty pharmaceutical benefits as part of its ongoing fiscal planning. This funding decision addresses rising costs for advanced medical treatments within the national healthcare system.